A. Achour et al., ENVELOPE PROTEIN AND P18(IIIB) PEPTIDE RECOGNIZED BY CYTOTOXIC T-LYMPHOCYTES FROM HUMANS IMMUNIZED WITH HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE, Vaccine, 11(7), 1993, pp. 699-701
Cytotoxic T cells are the main antigen-specific effector cells of the
cellular immune system and MHC class I restricted cytotoxic T-lymphocy
te (CTL) responses in mice, acting against the HIV-1 envelope protein,
are known to be predominantly directed against an amino acid sequence
in the third hypervariable domain. We have investigated the epitope s
pecificity of anti-HIV-1 CTL in healthy human volunteers inoculated wi
th a recombinant vaccinia expressing the HIV-1 gp160 envelope gene. Th
eir isolated lymphocytes were stimulated in vitro with autologous HIV-
1 infected cells. Our results show that immunization with recombinant
virus is able to generate virus-specific CTLs to the HIV-1 gp160 envel
ope protein and to a 15-residue synthetic peptide corresponding to a h
ighly variable region of the envelope p18(IIIB). The CTL response was
restricted by class I MHC molecules HLA-A2 and A3 that commonly occur
in the human population.